Abstract:
The invention provides a method of using pregnadienones and pregnadienols represented by the structural formula (I) as shown herein below 1 Wherein XnullOH or O or combination thereof and positioning of olefinic bonds are at 4(5); 5(6); 6(17); 17(20) or various combinations and said compounds containing at least one olefinic bond in or on their D-ring for the treatment of hypolipidemic and hypoglycemic conditions in mammals, said method comprising administering an effective amount of the said compounds to the recipient mammals.